Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA2256 PaquinimodSummary: Paquinimod (ABR215757) is a specific inhibitor with oral activity. -
BA2257 GSK3326595Summary: GSK3326595 is a protein arginine methyltransferase 5 inhibitor. -
BA2258 ZotatifinSummary: Zotatifin (eFT226) is a potent, selective and well-tolerated eIF4A inhibitor. -
BA2259 EnsitrelvirSummary: Ensitrelvir (S-217622) is the first to be orally active. -
BA2262 LP-935509Summary: LP-935509 is an orally potent, selective, ATP-competitive, and blood-brain barrier-crossing inhibitor of junctional protein-2-related kinase 1. -
BA2263 MerafloxacinSummary: Merafloxacin (CI-934), a fluoroquinolone antimicrobial agent, is a selective programmed-1 ribosome translocation inhibitor of beta viruses. -
BA2265 PF-00835231Summary: PF-00835231 is an inhibitor of a major viral protease. -
BA2266 EnoxaparinSummary: Enoxaparin (PK10169) is a low molecular heparin (LMWH) derivative. -
BA2267 IbuzatrelvirSummary: Ibuzatrelvir (PF-07817883), second-generation oral bioavailability, is a SARS-CoV-2 major protease (and) inhibitor with improved metabolic stability. -
BA2269 GS-621763Summary: GS-621763 is an orally effective precursor to GS-441524.

